Corbus Pharmaceuticals Holdings (CRBP) Other Working Capital Changes (2019)

Corbus Pharmaceuticals Holdings has reported Other Working Capital Changes for 1 years, with the latest figure at -$29.5 million in Q2 2019.

• On a quarterly basis, Other Working Capital Changes fell 11.51% year-over-year to -$407000.0 in Q3 2025; TTM through Sep 2025 was -$1.6 million, a 11.66% decrease from a year earlier, with the FY2024 full-year figure at -$1.4 million, down 12.18% from the prior year.
• Other Working Capital Changes was -$407000.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, down from -$399000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was -$237592.0 in Q1 2021, with the low at -$407000.0 in Q3 2025.
• Average Other Working Capital Changes over 5 years is -$318368.9, with a median of -$319263.0 recorded in 2023.
• The largest YoY upside for Other Working Capital Changes was 94.6% in 2021 against a maximum downside of 162.7% in 2021.
• Over 5 years, Other Working Capital Changes stood at -$260600.0 in 2021, then dropped by 13.13% to -$294821.0 in 2022, then retreated by 12.61% to -$332000.0 in 2023, then dropped by 11.75% to -$371000.0 in 2024, then dropped by 9.7% to -$407000.0 in 2025.
• The last three Other Working Capital Changes figures came in at -$407000.0 (Q3 2025), -$399000.0 (Q2 2025), and -$384000.0 (Q1 2025), per Business Quant data.